Chemomab Therapeutics Ltd. (CMMB): Shareholders' Equity
$12.33M
As of 2025-12-31
-30.2%
3-year compound annual growth
+2.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.33M | -8.9% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $13.54M | -20.4% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $17.00M | -53.1% | 2026-03-23, Balance as of period end |
| 2022-12-31 | $36.22M | -41.1% | 2025-04-04, Balance as of period end |
| 2021-12-31 | $61.47M | +469.0% | 2024-03-28, Balance as of period end |
| 2020-12-31 | $10.80M | n/c | 2022-03-30, Balance as of period end |
| 2019-12-31 | $14.91M | +52.1% | 2021-03-09, Balance as of period end |
| 2018-12-31 | $9.80M | n/a | 2020-03-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | $12.33M | -8.9% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | -$109.72M | n/m |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | $7.92M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$6.64M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | $3.93M | -42.0% |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $12.45M | +528.5% |
| Biovie Inc. (BIVI) | 2026-06-30 | $10.27M | -46.0% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$15.94M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
Compare CMMB, CYDY, ACTU, CALC side by side · Screen every company in Pharmaceutical Preparations ↗